← SynDRA
HKI-357
SynDRA canonical compound SYN0005561 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
|---|
| Primary target(s) | EGFR |
|---|
| Mechanism of action | EGFR inhibitor |
|---|
All known targets
Mechanisms of action (all sources)
Cross-references
Synonyms
- UNII-39R3638KZ6
- RefChem:146608
- DTXCID50156364
- MFCD26792555
- C31H29ClFN5O3
- orb1309572
- SCHEMBL2203413
- SCHEMBL29351355
- SCHEMBL29351364
- SCHEMBL29478857
- EX-A6770
- YIB13317
- BDBM50161908
- AKOS022175080
- MS-30340
- DB-327913
- HY-103443
- CS-0027900
- HKI-357; HKI357; HKI 357
- NS00071808
- G14301
- T11569
- BRD-K58811567-001-01-9
- BRD-K58811567-001-02-7
- hki-357 dimaleate
- HKI-357 (dimaleate)
- 7X764DR931
- CS-1228378
- HKI-357 dimaleate
- T68360
- UNII-7X764DR931
- orb1741120
Look up HKI-357 in the interactive SynDRA portal →